CLEC4A and hepatocellular carcinoma: Among the top five positive associations were MARCH1, TLR4, and CLEC4A. In hepatocellular carcinoma, MARCH1 regulates the PI3K-AKT-β-catenin pathway, thereby promoting tumor progression (Xie et al. 2019).